Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Department of Neurology, State of New York Downstate Health Sciences University, Brooklyn, NY.
J Acquir Immune Defic Syndr. 2022 Jan 1;89(1):1-8. doi: 10.1097/QAI.0000000000002822.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) symptoms among people living with HIV (PLWH) are not well described.
Longitudinal survey within the MACS/WIHS Combined Cohort Study (MWCCS) of PLWH compared with similar HIV-seronegative (SN) individuals.
Telephone-administered survey of MWCCS participants at 13 clinical research sites across the United States addressing COVID-19 symptoms, SARS-CoV-2 testing, and pandemic impact on social distancing and antiretroviral therapy (ART) use. Primary data collection occurred during May (wave 1), June-July (wave 2), and August-September, 2020 (wave 3).
One-third of MWCCS participants were tested for SARS-CoV-2 infection; 10% was tested ≥2 times. Similar proportions of PLWH and SN participants were tested, but SARS-CoV-2 positivity was higher among PLWH than among SN individuals (9.4% vs 4.8%, P = 0.003). Odds of SARS-CoV-2 positivity remained higher among PLWH after adjusting for age, sex, race/ethnicity, and study site (adjusted odds ratio = 2.0, 95% confidence interval = 1.2 to 3.2). SARS-CoV-2 positivity was not associated with CD4 cell counts among PLWH. Among SARS-CoV-2 positive participants, 9% had no symptoms, 7% had 1-2 mild symptoms, and 84% had ≥3 symptoms. Most of the (98%) participants reported physical distancing during all survey waves; self-reported ART adherence among PLWH was not adversely affected during the pandemic compared with the previous year (similar adherence in 89% of participants, improved in 9% of participants, and decreased in 2% of participants).
Despite similar SARS-CoV-2 testing and physical distancing profiles by HIV serostatus among MWCCS participants, PLWH who reported SARS-CoV-2 testing were more likely to have a positive test result. Additional studies are needed to determine whether and why PLWH are at increased risk of SARS-CoV-2 infection.
人们对于感染严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)和患有 2019 年冠状病毒病(COVID-19)的艾滋病毒感染者(PLWH)的症状知之甚少。
在美国的 MACS/WIHS 联合队列研究(MWCCS)中对 PLWH 进行的纵向调查,与类似的 HIV 血清阴性(SN)个体进行了比较。
通过电话对美国 13 个临床研究地点的 MWCCS 参与者进行调查,调查内容涉及 COVID-19 症状、SARS-CoV-2 检测以及大流行对社交距离和抗逆转录病毒治疗(ART)使用的影响。主要数据收集发生在 2020 年 5 月(第 1 波)、6-7 月(第 2 波)和 8-9 月(第 3 波)。
MWCCS 参与者中有三分之一接受了 SARS-CoV-2 感染检测;10%的人接受了≥2 次检测。PLWH 和 SN 参与者接受检测的比例相似,但 PLWH 中 SARS-CoV-2 阳性的比例高于 SN 个体(9.4%比 4.8%,P=0.003)。在调整了年龄、性别、种族/族裔和研究地点后,PLWH 中 SARS-CoV-2 阳性的可能性仍然更高(调整后的优势比=2.0,95%置信区间=1.2 至 3.2)。PLWH 中 SARS-CoV-2 阳性与 CD4 细胞计数无关。在 SARS-CoV-2 阳性参与者中,9%没有症状,7%有 1-2 种轻度症状,84%有≥3 种症状。大多数(98%)参与者在所有调查波次都报告了保持社交距离;与前一年相比,PLWH 的自我报告的 ART 依从性在大流行期间并未受到不利影响(89%的参与者保持相同的依从性,9%的参与者有所改善,2%的参与者有所下降)。
尽管 MWCCS 参与者中 HIV 血清学状况相似的 SARS-CoV-2 检测和保持社交距离的情况相似,但报告 SARS-CoV-2 检测的 PLWH 更有可能检测结果呈阳性。需要进一步研究来确定 PLWH 是否以及为何面临更高的 SARS-CoV-2 感染风险。